Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Express Scripts
Johnson and Johnson
Chinese Patent Office
Argus Health

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074035

« Back to Dashboard

NDA 074035 describes KETOPROFEN, which is a drug marketed by Actavis Labs Fl Inc, Alkermes Gainesville, Mylan, Aurolife Pharma Llc, Heritage Pharms Inc, Teva, and Perrigo, and is included in ten NDAs. It is available from sixteen suppliers. Additional details are available on the KETOPROFEN profile page.

The generic ingredient in KETOPROFEN is ketoprofen. There are twenty-seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.

Summary for 074035

Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 074035

Medical Subject Heading (MeSH) Categories for 074035

Suppliers and Packaging for NDA: 074035

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
KETOPROFEN ketoprofen CAPSULE;ORAL 074035 ANDA Mylan Pharmaceuticals Inc. 0378-4070 0378-4070-01 100 CAPSULE in 1 BOTTLE (0378-4070-01)
KETOPROFEN ketoprofen CAPSULE;ORAL 074035 ANDA Mylan Pharmaceuticals Inc. 0378-5750 0378-5750-01 100 CAPSULE in 1 BOTTLE (0378-5750-01)

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength50MG
Approval Date:Dec 31, 1996TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength75MG
Approval Date:Dec 31, 1996TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Express Scripts
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: